ST

Sanjay Trehan

Active Director Whole-Time Director DIN 10936402
DIN 10936402 First appointment Feb 2025 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Feb 2025
Shareholding value •••• Premium profile

About Sanjay Trehan

Data last updated:

Sanjay Trehan is a Whole-Time Director at Panacea Biotec Limited (since 2025), Whole-Time Director at Panacea Biotec Pharma Limited (since 2025) and Whole-Time Director at Panacea Biotec Pharma Limited (since 2025). The companies operate in Life Sciences and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹1,115 Cr; the largest is Panacea Biotec Limited at ₹585 Cr (FY 2024).

DIN 10936402
Primary Designation Whole-Time Director
Industry Life Sciences
First Appointment 13 Feb 2025
Oldest Company Age 42 yrs
Largest company Panacea Biotec Limited · ₹585 Cr (FY 2024)
Combined revenue ₹1,115 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Panacea Biotec Limited L33117PB1984PLC022350
Whole-Time Director14 Feb 20251984₹585 Cr (FY 2024)Active
Panacea Biotec Pharma Limited U24299DL2019PLC347566
Whole-Time Director13 Feb 20252019₹265 Cr (FY 2025)Active
Panacea Biotec Pharma Limited U24299PB2019PLC068319
Whole-Time Director13 Feb 20252019₹265 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Panacea Biotec Pharma Limited
Panacea Biotec Limited
Panacea Biotec Pharma Limited
Premium access

Shareholding and investment profile for Sanjay Trehan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Trehan

Sanjay Trehan currently holds 3 directorships: Panacea Biotec Limited (Whole-Time Director, since 14 Feb 2025, revenue ₹585 Cr (FY 2024)); Panacea Biotec Pharma Limited (Whole-Time Director, since 13 Feb 2025, revenue ₹265 Cr (FY 2025)); Panacea Biotec Pharma Limited (Whole-Time Director, since 13 Feb 2025, revenue ₹265 Cr (FY 2025)).

Sanjay Trehan was first appointed on 13 Feb 2025 as Whole-Time Director at Panacea Biotec Pharma Limited.

The 3 current companies of Sanjay Trehan that report revenue have a combined latest revenue of ₹1,115 Cr: Panacea Biotec Limited ₹585 Cr (FY 2024); Panacea Biotec Pharma Limited ₹265 Cr (FY 2025); Panacea Biotec Pharma Limited ₹265 Cr (FY 2025).

The current boards of Sanjay Trehan's companies include Ambika Sharma (Panacea Biotec Limited), Ankesh Jain (Panacea Biotec Limited), Ankit Jain (Panacea Biotec Limited), Harshet Jain (Panacea Biotec Limited), Krishan Kumar Jalan (Panacea Biotec Limited), Rajender Pal Singh (Panacea Biotec Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available